FEATURED STOCK

Chelsea Therapeutics International Ltd (NASDAQ: CHTP)

•  
•  
•  
• 

3.88+1.47+61.00%fday's Close  |  3.95 +0.07 +1.80% After hours

MORE ON CHTP

• SUMMARY
• Quote
• Options
• Historical Prices
• CHARTS
• Interactive Chart
• NEWS
• Headlines
• Key Developments
• FUNDAMENTALS
• Financial Highlights
• Profile
• Key Ratios
• 10-Year Summary
• Earnings
• SEC Filings
• RATINGS/ANALYSIS
• StockScouter Report
• Analyst Ratings
• INSIDER ACTION
• Insider Trades
• Ownership
• FINANCIALS
• Income Statement
• Balance Sheet
• Cash Flow
•  

COMPANY ADDRESS

Chelsea Therapeutics International Ltd
13950 Ballantyne
Suite 200, 3530 Toringdon Way
CHARLOTTE, NC 28277
US - Map
Phone: 704-3411516
Fax: 302-5313150
Website 

COMPANY INFORMATION

Exchange:	NASDAQ
Stock:	Chelsea Therapeutics International Ltd.
Industry:	Biotechnology
Employees:	30

DESCRIPTION

Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), associated with primary autonomic failure and falls related to NOH in Parkinson’s Disease (PD), as well as other norepinephrine-related conditions and diseases, including intradialytic hypotension (IDH), fibromyalgia, adult attention deficit hyperactivity disorder (ADHD), chronic fatigue syndrome (CFS), freezing of gait in PD and Down syndrome. In addition, the Company is developing a portfolio of metabolically inert antifolates for the treatment of rheumatoid arthritis and is exploring potential applications in multiple other autoimmune disorders.